Rosiglitazone reduces plasma insulin & its precursors while decreasing glycaemia in type 2 diabetics.

被引：0
|
作者：
Jones, NP
Charbonnel, B
Lönnqvist, F
Owen, S
Patwardhan, R
机构：
来源：
DIABETOLOGIA | 1999年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
859
引用
下载
收藏
页码：A229 / A229
页数：1
相关论文
共 50 条
  • [31] Hypertension did not alter whole body insulin resistance and skeletal muscle glucose utilization but increased plasma fasting insulin in type-2 diabetics
    Yokoyama, I
    Yonekura, K
    Nagai, R
    DIABETES, 2000, 49 : A96 - A96
  • [32] Model analysis of β-cell function in first-degree relatives of type 2 diabetics and its relation to insulin resistance
    Mari, A
    Oestergaard, T
    Nyholm, B
    Schmitz, O
    Ferrannini, E
    DIABETES, 2002, 51 : A360 - A360
  • [33] Vitamin D status and its association with insulin resistance among type 2 diabetics: A case -control study in Ghana
    Fondjo, Linda Ahenkorah
    Owiredu, William K. B. A.
    Sakyi, Samuel Asamoah
    Laing, Edwin Ferguson
    Adotey-Kwofie, Michael Acquaye
    Antoh, Enoch Odame
    Detoh, Eric
    PLOS ONE, 2017, 12 (04):
  • [34] Long-term metformin use reduces gastric cancer risk in type 2 diabetics without insulin treatment: a nationwide cohort study
    Kim, Y. -I.
    Kim, S. Y.
    Cho, S. -J.
    Park, J. -H.
    Choi, I. J.
    Lee, Y. J.
    Lee, E. K.
    Kook, M. -C.
    Kim, C. G.
    Ryu, K. W.
    Kim, Y. -W.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (08) : 854 - 863
  • [35] Long-term metformin use reduces gastric cancer risk in type 2 diabetics without insulin treatment: a nationwide cohort study
    Cho, Soo-Jeong
    Kim, Young-Il
    Kim, So Young
    Park, Jong-Hyock
    Choi, Il Ju
    Lee, You Jin
    Lee, Eun Kyung
    Kook, Myeong-Cherl
    Kim, Chan Gyoo
    Ryu, Keun Won
    Kim, Young-Woo
    CANCER RESEARCH, 2014, 74 (19)
  • [36] Insulin resistance together with increased plasma insulin and plasminogen activator inhibitor 1 levels are strongly associated with recurrence of myocardial infarction in type 2 diabetics and in nondiabetics
    Lalic, K
    Ostojic, M
    Lalic, NM
    Kanjuh, V
    Zamaklar, M
    Jotic, A
    Rajkovic, N
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 54 - 54
  • [37] Effect of decreasing the plasma glucose concentration on the glucose and insulin area response to 50 grams of protein in males with type 2 diabetes mellitus
    Saeed, A
    Jones, SA
    Nuttall, JA
    Gannon, MC
    Nuttall, FQ
    DIABETES, 2000, 49 : A306 - A306
  • [38] Plasma LECT2 level and its correlation with insulin resistance in patients with type 2 diabetes mellitus
    Zeng, Huixian
    Zhang, Zhen
    Chen, Hong
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2017, 33
  • [39] Effect of rosiglitazone on insulin sensitivity, liver fat content C-reactive protein and plasma adiponectin in patients with Thai type 2 diabetic subjects
    Pratipanawatr, T
    Mailaing, E
    Pratipanawat, W
    DIABETES, 2004, 53 : A556 - A556
  • [40] First-line therapy with fixed-dose combination of rosiglitazone plus glimepiride improves insulin sensitivity and reduces cardiovascular risk markers in patients with type 2 diabetes
    Seidel, D.
    Segiet, T.
    Ferreira-Cornwell, C.
    Krebs, J. B.
    Chou, H. S.
    Goldstein, B. J.
    DIABETOLOGIA, 2006, 49 : 336 - 337
12345